CAP, Adenylate Cyclase-Associated Protein 1 (CAP1) (Middle Region) Peptide
Aperçu rapide pour CAP, Adenylate Cyclase-Associated Protein 1 (CAP1) (Middle Region) Peptide (ABIN974439)
Antigène
Origine
Source
Application
-
-
Protein Region
- Middle Region
-
Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-CAP1 antibody (Catalog #: ARP48296_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- CAP1 (CAP, Adenylate Cyclase-Associated Protein 1 (CAP1))
-
Sujet
-
The protein encoded by this gene is related to the S. cerevisiae CAP protein, which is involved in the cyclic AMP pathway. The human protein is able to interact with other molecules of the same protein, as well as with CAP2 and actin. Alternatively splice
Alias Symbols: CAP, CAP1-PEN
Protein Interaction Partner: ACTB,CAP1,CAP2,MYOC,SERPINB8,ACTG1,Bat3,CAP1,CAP2,CFL1,Cap1
Protein Size: 475 -
Poids moléculaire
- 52 kDa
-
ID gène
- 10487
-
NCBI Accession
- NM_006367, NP_006358
-
UniProt
- Q01518
Antigène
-